nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—psoriasis	0.144	1	CbGbCtD
Brimonidine—Hypertension—Prednisolone—psoriasis	0.000308	0.000359	CcSEcCtD
Brimonidine—Shock—Mycophenolate mofetil—psoriasis	0.000307	0.000358	CcSEcCtD
Brimonidine—Loss of consciousness—Hydrocortisone—psoriasis	0.000306	0.000357	CcSEcCtD
Brimonidine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000306	0.000357	CcSEcCtD
Brimonidine—Arrhythmia—Dexamethasone—psoriasis	0.000305	0.000357	CcSEcCtD
Brimonidine—Arrhythmia—Betamethasone—psoriasis	0.000305	0.000357	CcSEcCtD
Brimonidine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000304	0.000356	CcSEcCtD
Brimonidine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000303	0.000354	CcSEcCtD
Brimonidine—Bradycardia—Prednisone—psoriasis	0.000303	0.000354	CcSEcCtD
Brimonidine—Hypertension—Hydrocortisone—psoriasis	0.000301	0.000351	CcSEcCtD
Brimonidine—Discomfort—Prednisolone—psoriasis	0.0003	0.00035	CcSEcCtD
Brimonidine—Rash—Hydroxyurea—psoriasis	0.000298	0.000348	CcSEcCtD
Brimonidine—Erythema—Betamethasone—psoriasis	0.000298	0.000347	CcSEcCtD
Brimonidine—Erythema—Dexamethasone—psoriasis	0.000298	0.000347	CcSEcCtD
Brimonidine—Dermatitis—Hydroxyurea—psoriasis	0.000297	0.000347	CcSEcCtD
Brimonidine—Myalgia—Hydrocortisone—psoriasis	0.000296	0.000346	CcSEcCtD
Brimonidine—Headache—Hydroxyurea—psoriasis	0.000296	0.000345	CcSEcCtD
Brimonidine—Anxiety—Hydrocortisone—psoriasis	0.000295	0.000345	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000294	0.000344	CcSEcCtD
Brimonidine—Syncope—Triamcinolone—psoriasis	0.000294	0.000343	CcSEcCtD
Brimonidine—Discomfort—Hydrocortisone—psoriasis	0.000293	0.000342	CcSEcCtD
Brimonidine—Hypotension—Mycophenolate mofetil—psoriasis	0.000291	0.00034	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000291	0.00034	CcSEcCtD
Brimonidine—Oedema—Prednisolone—psoriasis	0.000291	0.00034	CcSEcCtD
Brimonidine—Insomnia—Cyclosporine—psoriasis	0.000289	0.000338	CcSEcCtD
Brimonidine—Loss of consciousness—Triamcinolone—psoriasis	0.000288	0.000337	CcSEcCtD
Brimonidine—Paraesthesia—Cyclosporine—psoriasis	0.000287	0.000335	CcSEcCtD
Brimonidine—Shock—Prednisolone—psoriasis	0.000286	0.000334	CcSEcCtD
Brimonidine—Cough—Triamcinolone—psoriasis	0.000286	0.000334	CcSEcCtD
Brimonidine—Dyspnoea—Cyclosporine—psoriasis	0.000285	0.000333	CcSEcCtD
Brimonidine—Somnolence—Cyclosporine—psoriasis	0.000284	0.000332	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000284	0.000332	CcSEcCtD
Brimonidine—Oedema—Hydrocortisone—psoriasis	0.000284	0.000332	CcSEcCtD
Brimonidine—Tachycardia—Prednisolone—psoriasis	0.000284	0.000332	CcSEcCtD
Brimonidine—Asthenia—Mycophenolic acid—psoriasis	0.000284	0.000331	CcSEcCtD
Brimonidine—Hypertension—Triamcinolone—psoriasis	0.000283	0.000331	CcSEcCtD
Brimonidine—Infection—Hydrocortisone—psoriasis	0.000282	0.00033	CcSEcCtD
Brimonidine—Insomnia—Mycophenolate mofetil—psoriasis	0.000282	0.000329	CcSEcCtD
Brimonidine—Dyspepsia—Cyclosporine—psoriasis	0.000281	0.000329	CcSEcCtD
Brimonidine—Nausea—Hydroxyurea—psoriasis	0.00028	0.000327	CcSEcCtD
Brimonidine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.00028	0.000327	CcSEcCtD
Brimonidine—Pruritus—Mycophenolic acid—psoriasis	0.00028	0.000327	CcSEcCtD
Brimonidine—Shock—Hydrocortisone—psoriasis	0.00028	0.000327	CcSEcCtD
Brimonidine—Myalgia—Triamcinolone—psoriasis	0.000279	0.000326	CcSEcCtD
Brimonidine—Nervous system disorder—Hydrocortisone—psoriasis	0.000279	0.000325	CcSEcCtD
Brimonidine—Eye disorder—Prednisone—psoriasis	0.000278	0.000325	CcSEcCtD
Brimonidine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000278	0.000325	CcSEcCtD
Brimonidine—Tachycardia—Hydrocortisone—psoriasis	0.000277	0.000324	CcSEcCtD
Brimonidine—Somnolence—Mycophenolate mofetil—psoriasis	0.000277	0.000324	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—psoriasis	0.000277	0.000324	CcSEcCtD
Brimonidine—Depression—Methotrexate—psoriasis	0.000276	0.000323	CcSEcCtD
Brimonidine—Flushing—Prednisone—psoriasis	0.000276	0.000323	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000276	0.000322	CcSEcCtD
Brimonidine—Skin disorder—Hydrocortisone—psoriasis	0.000276	0.000322	CcSEcCtD
Brimonidine—Discomfort—Triamcinolone—psoriasis	0.000276	0.000322	CcSEcCtD
Brimonidine—Fatigue—Cyclosporine—psoriasis	0.000276	0.000322	CcSEcCtD
Brimonidine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000275	0.000321	CcSEcCtD
Brimonidine—Pain—Cyclosporine—psoriasis	0.000273	0.000319	CcSEcCtD
Brimonidine—Dry mouth—Triamcinolone—psoriasis	0.000273	0.000319	CcSEcCtD
Brimonidine—Angiopathy—Prednisone—psoriasis	0.00027	0.000315	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—psoriasis	0.000269	0.000315	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000269	0.000315	CcSEcCtD
Brimonidine—Immune system disorder—Prednisone—psoriasis	0.000269	0.000314	CcSEcCtD
Brimonidine—Oedema—Triamcinolone—psoriasis	0.000268	0.000312	CcSEcCtD
Brimonidine—Syncope—Betamethasone—psoriasis	0.000267	0.000312	CcSEcCtD
Brimonidine—Syncope—Dexamethasone—psoriasis	0.000267	0.000312	CcSEcCtD
Brimonidine—Pain—Mycophenolate mofetil—psoriasis	0.000267	0.000312	CcSEcCtD
Brimonidine—Arrhythmia—Prednisone—psoriasis	0.000266	0.00031	CcSEcCtD
Brimonidine—Infection—Triamcinolone—psoriasis	0.000266	0.00031	CcSEcCtD
Brimonidine—Hypotension—Hydrocortisone—psoriasis	0.000266	0.00031	CcSEcCtD
Brimonidine—Shock—Triamcinolone—psoriasis	0.000263	0.000307	CcSEcCtD
Brimonidine—Insomnia—Prednisolone—psoriasis	0.000263	0.000307	CcSEcCtD
Brimonidine—Loss of consciousness—Dexamethasone—psoriasis	0.000261	0.000305	CcSEcCtD
Brimonidine—Loss of consciousness—Betamethasone—psoriasis	0.000261	0.000305	CcSEcCtD
Brimonidine—Dizziness—Mycophenolic acid—psoriasis	0.000261	0.000305	CcSEcCtD
Brimonidine—Paraesthesia—Prednisolone—psoriasis	0.000261	0.000305	CcSEcCtD
Brimonidine—Tachycardia—Triamcinolone—psoriasis	0.000261	0.000305	CcSEcCtD
Brimonidine—Mental disorder—Prednisone—psoriasis	0.000261	0.000305	CcSEcCtD
Brimonidine—Erythema—Prednisone—psoriasis	0.000259	0.000303	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000259	0.000302	CcSEcCtD
Brimonidine—Insomnia—Hydrocortisone—psoriasis	0.000257	0.0003	CcSEcCtD
Brimonidine—Hypertension—Dexamethasone—psoriasis	0.000257	0.0003	CcSEcCtD
Brimonidine—Hypertension—Betamethasone—psoriasis	0.000257	0.0003	CcSEcCtD
Brimonidine—Paraesthesia—Hydrocortisone—psoriasis	0.000255	0.000298	CcSEcCtD
Brimonidine—Myalgia—Dexamethasone—psoriasis	0.000253	0.000296	CcSEcCtD
Brimonidine—Myalgia—Betamethasone—psoriasis	0.000253	0.000296	CcSEcCtD
Brimonidine—Anxiety—Betamethasone—psoriasis	0.000252	0.000295	CcSEcCtD
Brimonidine—Anxiety—Dexamethasone—psoriasis	0.000252	0.000295	CcSEcCtD
Brimonidine—Discomfort—Betamethasone—psoriasis	0.00025	0.000292	CcSEcCtD
Brimonidine—Discomfort—Dexamethasone—psoriasis	0.00025	0.000292	CcSEcCtD
Brimonidine—Dyspepsia—Hydrocortisone—psoriasis	0.00025	0.000292	CcSEcCtD
Brimonidine—Rash—Mycophenolic acid—psoriasis	0.000249	0.000291	CcSEcCtD
Brimonidine—Dermatitis—Mycophenolic acid—psoriasis	0.000249	0.000291	CcSEcCtD
Brimonidine—Pain—Prednisolone—psoriasis	0.000249	0.000291	CcSEcCtD
Brimonidine—Headache—Mycophenolic acid—psoriasis	0.000248	0.000289	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—psoriasis	0.000247	0.000288	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000245	0.000287	CcSEcCtD
Brimonidine—Fatigue—Hydrocortisone—psoriasis	0.000245	0.000286	CcSEcCtD
Brimonidine—Vision blurred—Prednisone—psoriasis	0.000244	0.000285	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000244	0.000285	CcSEcCtD
Brimonidine—Pain—Hydrocortisone—psoriasis	0.000243	0.000284	CcSEcCtD
Brimonidine—Oedema—Dexamethasone—psoriasis	0.000243	0.000284	CcSEcCtD
Brimonidine—Oedema—Betamethasone—psoriasis	0.000243	0.000284	CcSEcCtD
Brimonidine—Insomnia—Triamcinolone—psoriasis	0.000242	0.000283	CcSEcCtD
Brimonidine—Infection—Betamethasone—psoriasis	0.000241	0.000282	CcSEcCtD
Brimonidine—Infection—Dexamethasone—psoriasis	0.000241	0.000282	CcSEcCtD
Brimonidine—Paraesthesia—Triamcinolone—psoriasis	0.00024	0.000281	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—psoriasis	0.00024	0.00028	CcSEcCtD
Brimonidine—Shock—Dexamethasone—psoriasis	0.000239	0.000279	CcSEcCtD
Brimonidine—Shock—Betamethasone—psoriasis	0.000239	0.000279	CcSEcCtD
Brimonidine—Dyspnoea—Triamcinolone—psoriasis	0.000239	0.000279	CcSEcCtD
Brimonidine—Nervous system disorder—Dexamethasone—psoriasis	0.000238	0.000278	CcSEcCtD
Brimonidine—Nervous system disorder—Betamethasone—psoriasis	0.000238	0.000278	CcSEcCtD
Brimonidine—Tachycardia—Betamethasone—psoriasis	0.000237	0.000277	CcSEcCtD
Brimonidine—Tachycardia—Dexamethasone—psoriasis	0.000237	0.000277	CcSEcCtD
Brimonidine—Hypersensitivity—Cyclosporine—psoriasis	0.000236	0.000275	CcSEcCtD
Brimonidine—Dyspepsia—Triamcinolone—psoriasis	0.000236	0.000275	CcSEcCtD
Brimonidine—Nausea—Mycophenolic acid—psoriasis	0.000235	0.000274	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—psoriasis	0.000232	0.000271	CcSEcCtD
Brimonidine—Syncope—Prednisone—psoriasis	0.000232	0.000271	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—psoriasis	0.000231	0.00027	CcSEcCtD
Brimonidine—Fatigue—Triamcinolone—psoriasis	0.000231	0.000269	CcSEcCtD
Brimonidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00023	0.000268	CcSEcCtD
Brimonidine—Asthenia—Cyclosporine—psoriasis	0.000229	0.000268	CcSEcCtD
Brimonidine—Pain—Triamcinolone—psoriasis	0.000229	0.000267	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisone—psoriasis	0.000228	0.000266	CcSEcCtD
Brimonidine—Hypotension—Dexamethasone—psoriasis	0.000227	0.000265	CcSEcCtD
Brimonidine—Hypotension—Betamethasone—psoriasis	0.000227	0.000265	CcSEcCtD
Brimonidine—Pruritus—Cyclosporine—psoriasis	0.000226	0.000264	CcSEcCtD
Brimonidine—Angiopathy—Methotrexate—psoriasis	0.000226	0.000264	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—psoriasis	0.000225	0.000262	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—psoriasis	0.000224	0.000262	CcSEcCtD
Brimonidine—Asthenia—Mycophenolate mofetil—psoriasis	0.000224	0.000261	CcSEcCtD
Brimonidine—Hypertension—Prednisone—psoriasis	0.000224	0.000261	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000221	0.000258	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000221	0.000258	CcSEcCtD
Brimonidine—Pruritus—Mycophenolate mofetil—psoriasis	0.000221	0.000258	CcSEcCtD
Brimonidine—Arthralgia—Prednisone—psoriasis	0.000221	0.000258	CcSEcCtD
Brimonidine—Myalgia—Prednisone—psoriasis	0.000221	0.000258	CcSEcCtD
Brimonidine—Anxiety—Prednisone—psoriasis	0.00022	0.000257	CcSEcCtD
Brimonidine—Insomnia—Dexamethasone—psoriasis	0.00022	0.000256	CcSEcCtD
Brimonidine—Insomnia—Betamethasone—psoriasis	0.00022	0.000256	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000219	0.000256	CcSEcCtD
Brimonidine—Paraesthesia—Dexamethasone—psoriasis	0.000218	0.000255	CcSEcCtD
Brimonidine—Paraesthesia—Betamethasone—psoriasis	0.000218	0.000255	CcSEcCtD
Brimonidine—Discomfort—Prednisone—psoriasis	0.000218	0.000255	CcSEcCtD
Brimonidine—Mental disorder—Methotrexate—psoriasis	0.000218	0.000254	CcSEcCtD
Brimonidine—Erythema—Methotrexate—psoriasis	0.000217	0.000253	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisolone—psoriasis	0.000214	0.00025	CcSEcCtD
Brimonidine—Dyspepsia—Betamethasone—psoriasis	0.000214	0.00025	CcSEcCtD
Brimonidine—Dyspepsia—Dexamethasone—psoriasis	0.000214	0.00025	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—psoriasis	0.000212	0.000248	CcSEcCtD
Brimonidine—Dizziness—Cyclosporine—psoriasis	0.000211	0.000247	CcSEcCtD
Brimonidine—Oedema—Prednisone—psoriasis	0.000211	0.000247	CcSEcCtD
Brimonidine—Infection—Prednisone—psoriasis	0.00021	0.000245	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00021	0.000245	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Betamethasone—psoriasis	0.00021	0.000245	CcSEcCtD
Brimonidine—Hypersensitivity—Hydrocortisone—psoriasis	0.000209	0.000245	CcSEcCtD
Brimonidine—Fatigue—Dexamethasone—psoriasis	0.000209	0.000244	CcSEcCtD
Brimonidine—Fatigue—Betamethasone—psoriasis	0.000209	0.000244	CcSEcCtD
Brimonidine—Shock—Prednisone—psoriasis	0.000208	0.000243	CcSEcCtD
Brimonidine—Pain—Betamethasone—psoriasis	0.000208	0.000242	CcSEcCtD
Brimonidine—Pain—Dexamethasone—psoriasis	0.000208	0.000242	CcSEcCtD
Brimonidine—Nervous system disorder—Prednisone—psoriasis	0.000207	0.000242	CcSEcCtD
Brimonidine—Tachycardia—Prednisone—psoriasis	0.000206	0.000241	CcSEcCtD
Brimonidine—Dizziness—Mycophenolate mofetil—psoriasis	0.000206	0.000241	CcSEcCtD
Brimonidine—Skin disorder—Prednisone—psoriasis	0.000205	0.00024	CcSEcCtD
Brimonidine—Vision blurred—Methotrexate—psoriasis	0.000204	0.000238	CcSEcCtD
Brimonidine—Asthenia—Hydrocortisone—psoriasis	0.000204	0.000238	CcSEcCtD
Brimonidine—Rash—Cyclosporine—psoriasis	0.000202	0.000235	CcSEcCtD
Brimonidine—Dermatitis—Cyclosporine—psoriasis	0.000201	0.000235	CcSEcCtD
Brimonidine—Pruritus—Hydrocortisone—psoriasis	0.000201	0.000235	CcSEcCtD
Brimonidine—Headache—Cyclosporine—psoriasis	0.0002	0.000234	CcSEcCtD
Brimonidine—Hypersensitivity—Triamcinolone—psoriasis	0.000197	0.00023	CcSEcCtD
Brimonidine—Rash—Mycophenolate mofetil—psoriasis	0.000197	0.00023	CcSEcCtD
Brimonidine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000197	0.000229	CcSEcCtD
Brimonidine—Headache—Mycophenolate mofetil—psoriasis	0.000195	0.000228	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000193	0.000225	CcSEcCtD
Brimonidine—Dizziness—Prednisolone—psoriasis	0.000192	0.000225	CcSEcCtD
Brimonidine—Asthenia—Triamcinolone—psoriasis	0.000192	0.000224	CcSEcCtD
Brimonidine—Insomnia—Prednisone—psoriasis	0.000191	0.000223	CcSEcCtD
Brimonidine—Nausea—Cyclosporine—psoriasis	0.00019	0.000222	CcSEcCtD
Brimonidine—Paraesthesia—Prednisone—psoriasis	0.00019	0.000222	CcSEcCtD
Brimonidine—Pruritus—Triamcinolone—psoriasis	0.000189	0.000221	CcSEcCtD
Brimonidine—Cough—Methotrexate—psoriasis	0.000189	0.000221	CcSEcCtD
Brimonidine—Dizziness—Hydrocortisone—psoriasis	0.000188	0.000219	CcSEcCtD
Brimonidine—Dyspepsia—Prednisone—psoriasis	0.000186	0.000217	CcSEcCtD
Brimonidine—Nausea—Mycophenolate mofetil—psoriasis	0.000185	0.000216	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—psoriasis	0.000184	0.000215	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—psoriasis	0.000184	0.000215	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—psoriasis	0.000184	0.000215	CcSEcCtD
Brimonidine—Rash—Prednisolone—psoriasis	0.000183	0.000214	CcSEcCtD
Brimonidine—Dermatitis—Prednisolone—psoriasis	0.000183	0.000214	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000183	0.000214	CcSEcCtD
Brimonidine—Fatigue—Prednisone—psoriasis	0.000182	0.000213	CcSEcCtD
Brimonidine—Headache—Prednisolone—psoriasis	0.000182	0.000213	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—psoriasis	0.000182	0.000213	CcSEcCtD
Brimonidine—Rash—Hydrocortisone—psoriasis	0.000179	0.000209	CcSEcCtD
Brimonidine—Dermatitis—Hydrocortisone—psoriasis	0.000179	0.000209	CcSEcCtD
Brimonidine—Headache—Hydrocortisone—psoriasis	0.000178	0.000208	CcSEcCtD
Brimonidine—Dizziness—Triamcinolone—psoriasis	0.000177	0.000207	CcSEcCtD
Brimonidine—Infection—Methotrexate—psoriasis	0.000176	0.000205	CcSEcCtD
Brimonidine—Asthenia—Dexamethasone—psoriasis	0.000174	0.000203	CcSEcCtD
Brimonidine—Asthenia—Betamethasone—psoriasis	0.000174	0.000203	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—psoriasis	0.000173	0.000202	CcSEcCtD
Brimonidine—Nausea—Prednisolone—psoriasis	0.000173	0.000202	CcSEcCtD
Brimonidine—Pruritus—Dexamethasone—psoriasis	0.000172	0.000201	CcSEcCtD
Brimonidine—Pruritus—Betamethasone—psoriasis	0.000172	0.000201	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—psoriasis	0.000172	0.0002	CcSEcCtD
Brimonidine—Nausea—Hydrocortisone—psoriasis	0.000169	0.000197	CcSEcCtD
Brimonidine—Rash—Triamcinolone—psoriasis	0.000169	0.000197	CcSEcCtD
Brimonidine—Dermatitis—Triamcinolone—psoriasis	0.000169	0.000197	CcSEcCtD
Brimonidine—Headache—Triamcinolone—psoriasis	0.000168	0.000196	CcSEcCtD
Brimonidine—Hypotension—Methotrexate—psoriasis	0.000165	0.000193	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000161	0.000188	CcSEcCtD
Brimonidine—Dizziness—Betamethasone—psoriasis	0.000161	0.000188	CcSEcCtD
Brimonidine—Dizziness—Dexamethasone—psoriasis	0.000161	0.000188	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—psoriasis	0.00016	0.000187	CcSEcCtD
Brimonidine—Nausea—Triamcinolone—psoriasis	0.000159	0.000186	CcSEcCtD
Brimonidine—Paraesthesia—Methotrexate—psoriasis	0.000159	0.000185	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—psoriasis	0.000158	0.000184	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—psoriasis	0.000157	0.000183	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisone—psoriasis	0.000156	0.000182	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—psoriasis	0.000156	0.000182	CcSEcCtD
Brimonidine—Rash—Betamethasone—psoriasis	0.000153	0.000179	CcSEcCtD
Brimonidine—Rash—Dexamethasone—psoriasis	0.000153	0.000179	CcSEcCtD
Brimonidine—Dermatitis—Dexamethasone—psoriasis	0.000153	0.000179	CcSEcCtD
Brimonidine—Dermatitis—Betamethasone—psoriasis	0.000153	0.000179	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000153	0.000178	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—psoriasis	0.000152	0.000178	CcSEcCtD
Brimonidine—Headache—Dexamethasone—psoriasis	0.000152	0.000178	CcSEcCtD
Brimonidine—Headache—Betamethasone—psoriasis	0.000152	0.000178	CcSEcCtD
Brimonidine—Asthenia—Prednisone—psoriasis	0.000152	0.000177	CcSEcCtD
Brimonidine—Pain—Methotrexate—psoriasis	0.000151	0.000176	CcSEcCtD
Brimonidine—Pruritus—Prednisone—psoriasis	0.00015	0.000175	CcSEcCtD
Brimonidine—Nausea—Dexamethasone—psoriasis	0.000144	0.000168	CcSEcCtD
Brimonidine—Nausea—Betamethasone—psoriasis	0.000144	0.000168	CcSEcCtD
Brimonidine—Dizziness—Prednisone—psoriasis	0.00014	0.000163	CcSEcCtD
Brimonidine—Rash—Prednisone—psoriasis	0.000133	0.000156	CcSEcCtD
Brimonidine—Dermatitis—Prednisone—psoriasis	0.000133	0.000156	CcSEcCtD
Brimonidine—Headache—Prednisone—psoriasis	0.000132	0.000155	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—psoriasis	0.00013	0.000152	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—psoriasis	0.000127	0.000148	CcSEcCtD
Brimonidine—Nausea—Prednisone—psoriasis	0.000126	0.000147	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—psoriasis	0.000125	0.000146	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—psoriasis	0.000117	0.000136	CcSEcCtD
Brimonidine—Rash—Methotrexate—psoriasis	0.000111	0.00013	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—psoriasis	0.000111	0.00013	CcSEcCtD
Brimonidine—Headache—Methotrexate—psoriasis	0.000111	0.000129	CcSEcCtD
Brimonidine—Nausea—Methotrexate—psoriasis	0.000105	0.000123	CcSEcCtD
